Biomedical and Biotechnology Research Journal (BBRJ)

REVIEW ARTICLE
Year
: 2022  |  Volume : 6  |  Issue : 3  |  Page : 311--318

Pseudomonas Aeruginosa a tenacious uropathogen: Increasing challenges and few solutions


Falah Hasan Obayes AL-Khikani, Aalae Salman Ayit 
 Department of Medical Technique, College of Medical Technique, The Islamic University; Department of Medical Microbiology, AL-Shomali General Hospital, Babylon, Iraq

Correspondence Address:
Falah Hasan Obayes AL-Khikani
Medical Laboratory Technology Department, College of Medical Technology, The Islamic University, Najaf
Iraq

No population in the world can be cleared from urinary tract infections (UTIs) that considered the most common bacterial infection globally, every year more than 150 million people suffering from acute or chronic UTI caused by various bacteria. It is among the most frequent health care-associated diseases. In patients with UTI, Pseudomonas aeruginosa deserves special attention since it can affect patients with serious underlying conditions. P. aeruginosa is a multidrug-resistant pathogen causing numerous chronic infections including urinary tract disorders. Infection caused by this organism is difficult to treat because of the presence of its innate resistance to many antibiotics and its ability to acquire further resistance mechanism to multiple classes of antibiotics, including beta-lactams, aminoglycosides, and fluoroquinolones; thus, the treatment option for these drug resistance pseudomonas are very limited. P. aeruginosa-induced UTIs continue to be linked with substantial mortality and morbidity. This adverse consequence is owing to our failure to create effective disease-prevention treatment methods, which is related to a lack of knowledge of resistance mechanisms. This study alerts researchers to the need to better understand the mechanisms of resistance in P. aeruginosa-caused UTIs to develop viable treatment options. The microbiological perspectives, virulence factors, epidemiology, mechanisms beyond antibiotic resistance, and antimicrobial sensitivity of P. aeruginosa in UTI are discussed in this review as well as future strategies to build basic information and clear vision to other researchers for more studies regarding this tenacious bacterium.


How to cite this article:
AL-Khikani FH, Ayit AS. Pseudomonas Aeruginosa a tenacious uropathogen: Increasing challenges and few solutions.Biomed Biotechnol Res J 2022;6:311-318


How to cite this URL:
AL-Khikani FH, Ayit AS. Pseudomonas Aeruginosa a tenacious uropathogen: Increasing challenges and few solutions. Biomed Biotechnol Res J [serial online] 2022 [cited 2022 Oct 3 ];6:311-318
Available from: https://www.bmbtrj.org/article.asp?issn=2588-9834;year=2022;volume=6;issue=3;spage=311;epage=318;aulast=AL-Khikani;type=0